940. Deputy Michael Collins asked the Minister for Health the reason the HSE has not yet approved funding for the drug dupixent (dupilumab) for adults with eosinophilic oesophagitis; the stage the pricing and assessment process is currently at; when a decision is expected; and if she will make a statement on the matter. [45320/26]

Summary

940. Deputy Michael Collins asked the Minister for Health the reason the HSE has not yet approved funding for the drug dupixent (dupilumab) for adults with eosinophilic oesophagitis; the stage the pricing and assessment process is currently at; when a decision is expected; and if she will make a statement on the matter. [45320/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 16 June 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.